Cellular Engineering Technologies and the nonprofit John Paul II Medical Research Institute (JP2MRI) are partnering to develop a private stem cell biobank. The collaboration will create more than 5,000 patient- and disease-specific stem cell lines and other human cell lines to advance drug discovery and offer personalized medicine. These cell lines are derived from adult sources and do not include embryonic stem cells.
The CET/JP2MRI partnership will eliminate the barriers that typically affect government and academic bio-banks because stem cell donations will come directly from patients recruited from private practice physicians and private hospitals.
Pages: 1 2